Adults over 50 don’t trust online sources of health info: Health and pharma marketers must re-establish credibility with older patients who are skeptical of what they see online.
Bad actors flood the GLP-1 weight loss drug market: Until the cost of branded GLP-1s drops, illegal online pharmacies advertising falsified versions of the drugs will keep lingering.
CVS Health replaces CEO Karen Lynch: With its insurance arm, Aetna, failing to meet investors’ expectations, CVS’ decision to appoint a longtime pharmacy benefit manager exec as CEO could be just what the doctor ordered to start turning its financial fortunes around.
Could in-store health clinics drive grocery sales? A new report seems to think so. But the broader challenges of the retail clinic business model will likely be too difficult to overcome.
How high healthcare costs affect consumer behavior: We detail what US healthcare and pharma marketers need to know to attract consumers and build trust in their brands.
Virtual mental health platforms launch AI companions: But some AI tools have a reputation for unpredictable responses.
Healthcare stakeholders will increase digital health investments: But health tech vendors must deliver on key performance metrics such as clinical outcomes, cost savings, and user satisfaction to ensure they catch investment dollars.
High healthcare costs are forcing people to make difficult choices. Here’s the data you need to draw consumers to your brand and foster their trust in it.
Abridge reels in another $250M: The AI medical scribe market is heating up, but a market correction is likely forthcoming. Here’s why.
nternal studies revealed compulsive TikTok use harmed mental health and disrupted users’ responsibilities like sleep and school, intensifying legal battles against the platform.
Walgreens to close 1,200 stores over the next 3 years: The retail pharmacy chain will be hyper-focused on its surviving stores turning a profit. Between a decline in the customer experience and more convenient options emerging, that won’t be easy.
Consumers and doctors agree that pharma ads help patients: But marketers must still create ad campaigns that better represent patients’ real-life experiences.
Sanofi in talks to sell 50% stake in Opella: The pharma company joins other drugmakers shedding their consumer health businesses to better focus on bolstering their prescription drug pipelines.
Havas Lynx’s global healthcare influencer offering reflects channel shift: Marketers increasingly devote resources to digital channels that physicians are engaging with, like social media.
WeightWatchers is the latest company to offer compounded GLP-1s: Consumer demand for cheaper versions of GLP-1s is forcing even weight-loss industry legacy players to sell the meds.
Retail pharmacies’ plight is Amazon’s gain: The online pharmacy is doubling down on fast medication delivery to capture market share from pharmacy incumbents.
Employers don’t know how their Rx drug benefits are managed: They’re nearing their wits’ end with pharmacy benefit managers and the legal liabilities that arise from the mismanagement of prescription drug benefits.
Biogen, Talkiatry offer services to patients with postpartum depression: We examine whether drugmaker-telehealth tie-ups are what’s best for patients.
Activist investor takes $1B stake in Pfizer, eyes a performance turnaround: But to the drugmaker’s credit, its plan to diversify the therapeutic areas it will focus on moving forward should place it in line with investors’ expectations.
Patient care is being disrupted by cyberattacks: Cyberattacks aren’t just causing financial disruptions—they’re causing real patient harm, too.